Alkem Laboratories informs about disclosure

01 Mar 2025 Evaluate

Pursuant to Regulation 30 read with Schedule III of SEBI LODR Regulations and further to its earlier intimation dated 28th December, 2024, Alkem Laboratories has informed that the Company has received further order for Assessment Year 2021-22 passed by statutory authority under the Income-tax Act, 1961. The required details are enclosed herewith as Annexure A. The above information is also available on the website of the Company at www.alkemlabs.com.

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories Share Price

4704.10 -46.25 (-0.97%)
13-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1683.85
Dr. Reddys Lab 1107.85
Cipla 1461.60
Lupin 1969.05
Zydus Lifesciences 882.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...